A Randomized Study of Lapatinib With Radiation Versus Radiation Alone in Advanced Solid Tumor Cancer Patients Receiving Radiation Therapy for Metastatic Disease

Trial Profile

A Randomized Study of Lapatinib With Radiation Versus Radiation Alone in Advanced Solid Tumor Cancer Patients Receiving Radiation Therapy for Metastatic Disease

Discontinued
Phase of Trial: Phase 0

Latest Information Update: 13 Jul 2015

At a glance

  • Drugs Lapatinib (Primary)
  • Indications Glandular and epithelial neoplasms; Solid tumours
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jul 2015 Status changed from active, no longer recruiting to discontinued as per ClinicalTrials.gov record.
    • 11 Jun 2015 Planned End Date changed from 1 Aug 2016 to 1 Jun 2015 as reported by ClinicalTrials.gov record.
    • 22 Dec 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top